Search research articles
Contact Us
Filters
Showing results (41-50 of 124) with videos related to
Page
of 13
Sort By:
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
October 15, 2016
T-Cell Therapy Enabling Adenoviruses Coding for IL2 and TNFα Induce Systemic Immunomodulation in Mice With Spontaneous Melanoma
Siri Tähtinen, Carolin Blattner, Markus Vähä-Koskela, et al.
Cells
|
April 30, 2021
Systemic Delivery of Oncolytic Adenovirus to Tumors Using Tumor-Infiltrating Lymphocytes as Carriers
Joao Santos, Camilla Heiniö, Dafne Quixabeira, et al.
Plos One
|
August 14, 2008
Systemic therapy for cervical cancer with potentially regulatable oncolytic adenoviruses
Anna Kanerva, Sergio Lavilla-Alonso, Mari Raki, et al.
The Journal of Gene Medicine
|
April 27, 2011
Switching the fiber knob of oncolytic adenoviruses to avoid neutralizing antibodies in human cancer patients
Mari Raki, Merja Sarkioja, Sophie Escutenaire, et al.
Journal of Translational Medicine
|
August 24, 2010
Adenoviruses with an αvβ integrin targeting moiety in the fiber shaft or the HI-loop increase tumor specificity without compromising antitumor efficacy in magnetic resonance imaging of colorectal cancer metastases
Sergio Lavilla-Alonso, Gerd Bauerschmitz, Usama Abo-Ramadan, et al.
International Journal of Cancer
|
June 15, 2017
Adenoviral production of interleukin-2 at the tumor site removes the need for systemic postconditioning in adoptive cell therapy
Joao Manuel Santos, Riikka Havunen, Mikko Siurala, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
September 13, 2007
Oncolytic adenoviruses kill breast cancer initiating CD44+CD24-/low cells
Minna Eriksson, Kilian Guse, Gerd Bauerschmitz, et al.
Oncotarget
|
February 22, 2018
Interleukin 8 activity influences the efficacy of adenoviral oncolytic immunotherapy in cancer patients
Kristian Taipale, Siri Tähtinen, Riikka Havunen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 11, 2003
CD40 is expressed on ovarian cancer cells and can be utilized for targeting adenoviruses
Tanja Hakkarainen, Akseli Hemminki, Alexander V Pereboev, et al.
Oncoimmunology
|
April 9, 2016
Oncolytic virotherapy for treatment of breast cancer, including triple-negative breast cancer
Simona Bramante, Anniina Koski, Ilkka Liikanen, et al.
Page
of 13
Search research articles
Search
Showing results (41-50 of 124) with videos related to
Sort By:
Page
of 13
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
October 15, 2016
T-Cell Therapy Enabling Adenoviruses Coding for IL2 and TNFα Induce Systemic Immunomodulation in Mice With Spontaneous Melanoma
Siri Tähtinen, Carolin Blattner, Markus Vähä-Koskela, et al.
Cells
|
April 30, 2021
Systemic Delivery of Oncolytic Adenovirus to Tumors Using Tumor-Infiltrating Lymphocytes as Carriers
Joao Santos, Camilla Heiniö, Dafne Quixabeira, et al.
Plos One
|
August 14, 2008
Systemic therapy for cervical cancer with potentially regulatable oncolytic adenoviruses
Anna Kanerva, Sergio Lavilla-Alonso, Mari Raki, et al.
The Journal of Gene Medicine
|
April 27, 2011
Switching the fiber knob of oncolytic adenoviruses to avoid neutralizing antibodies in human cancer patients
Mari Raki, Merja Sarkioja, Sophie Escutenaire, et al.
Journal of Translational Medicine
|
August 24, 2010
Adenoviruses with an αvβ integrin targeting moiety in the fiber shaft or the HI-loop increase tumor specificity without compromising antitumor efficacy in magnetic resonance imaging of colorectal cancer metastases
Sergio Lavilla-Alonso, Gerd Bauerschmitz, Usama Abo-Ramadan, et al.
International Journal of Cancer
|
June 15, 2017
Adenoviral production of interleukin-2 at the tumor site removes the need for systemic postconditioning in adoptive cell therapy
Joao Manuel Santos, Riikka Havunen, Mikko Siurala, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
September 13, 2007
Oncolytic adenoviruses kill breast cancer initiating CD44+CD24-/low cells
Minna Eriksson, Kilian Guse, Gerd Bauerschmitz, et al.
Oncotarget
|
February 22, 2018
Interleukin 8 activity influences the efficacy of adenoviral oncolytic immunotherapy in cancer patients
Kristian Taipale, Siri Tähtinen, Riikka Havunen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 11, 2003
CD40 is expressed on ovarian cancer cells and can be utilized for targeting adenoviruses
Tanja Hakkarainen, Akseli Hemminki, Alexander V Pereboev, et al.
Oncoimmunology
|
April 9, 2016
Oncolytic virotherapy for treatment of breast cancer, including triple-negative breast cancer
Simona Bramante, Anniina Koski, Ilkka Liikanen, et al.
Page
of 13